Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
Irene van den Broek, Fred P.H.T.M. Romijn, Jan Nouta, et al.
Clinical Chemistry (2015) Vol. 62, Iss. 1, pp. 188-197
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses
L. Renee Ruhaak, Gege Xu, Qiongyu Li, et al.
Chemical Reviews (2018) Vol. 118, Iss. 17, pp. 7886-7930
Open Access | Times Cited: 337
HDL cholesterol: reappraisal of its clinical relevance
Winfried März, Marcus E. Kleber, Hubert Scharnagl, et al.
Clinical Research in Cardiology (2017) Vol. 106, Iss. 9, pp. 663-675
Open Access | Times Cited: 236
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois, M. John Chapman, Christa M. Cobbaert, et al.
Clinical Chemistry (2018) Vol. 64, Iss. 7, pp. 1006-1033
Open Access | Times Cited: 227
After another decade: LC–MS/MS became routine in clinical diagnostics
Christoph Seger, Linda Salzmann
Clinical Biochemistry (2020) Vol. 82, pp. 2-11
Open Access | Times Cited: 224
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Børge G. Nordestgaard, Michel R. Langlois, Anne Langsted, et al.
Atherosclerosis (2020) Vol. 294, pp. 46-61
Open Access | Times Cited: 202
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R. Langlois, Børge G. Nordestgaard, Anne Langsted, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2019) Vol. 58, Iss. 4, pp. 496-517
Open Access | Times Cited: 168
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
Tim West, Kristopher M. Kirmess, Matthew R. Meyer, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 163
Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision
Hendrik Neubert, Christopher M. Shuford, Timothy Olah, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 2, pp. 282-301
Open Access | Times Cited: 84
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests
L. Renee Ruhaak, Fred P.H.T.M. Romijn, Ilijana Begcevic Brkovic, et al.
Clinical Chemistry (2023) Vol. 69, Iss. 3, pp. 251-261
Open Access | Times Cited: 31
Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology
Baihe Sun, Guanghui Li, Yue Wu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58405-58416
Closed Access | Times Cited: 8
Highly Reproducible Automated Proteomics Sample Preparation Workflow for Quantitative Mass Spectrometry
Qin Fu, Michael Kowalski, Mitra Mastali, et al.
Journal of Proteome Research (2017) Vol. 17, Iss. 1, pp. 420-428
Open Access | Times Cited: 84
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja‐Riitta Taskinen, Jan Borén
Current Atherosclerosis Reports (2016) Vol. 18, Iss. 10
Open Access | Times Cited: 79
Biochemistry of the menopause
John W. Honour
Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2017) Vol. 55, Iss. 1, pp. 18-33
Open Access | Times Cited: 73
Recent advances in robotic protein sample preparation for clinical analysis and other biomedical applications
Michal Alexovič, Pawel L. Urban, Hadi Tabani, et al.
Clinica Chimica Acta (2020) Vol. 507, pp. 104-116
Closed Access | Times Cited: 67
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
Christa M. Cobbaert, Harald Althaus, Ilijana Begcevic Brkovic, et al.
Clinical Chemistry (2020) Vol. 67, Iss. 3, pp. 478-489
Open Access | Times Cited: 67
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
Michel R. Langlois, Allan D. Sniderman
Current Cardiology Reports (2020) Vol. 22, Iss. 8
Closed Access | Times Cited: 52
Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II–Operations
Brian A. Rappold
Annals of Laboratory Medicine (2022) Vol. 42, Iss. 5, pp. 531-557
Open Access | Times Cited: 37
Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease
Robert Clarke, Adam Von Ende, Lukas Schmidt, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 452-464
Open Access | Times Cited: 21
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Michael Szarek, Esther Reijnders, J. Wouter Jukema, et al.
Circulation (2023) Vol. 149, Iss. 3, pp. 192-203
Open Access | Times Cited: 20
Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
Mathijs C. Bodde, Maaike Hermans, J. Wouter Jukema, et al.
Clinical Research in Cardiology (2018) Vol. 108, Iss. 5, pp. 520-538
Open Access | Times Cited: 57
Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers
Irene van den Broek, Qin Fu, Stuart Kushon, et al.
Clinical mass spectrometry (2017) Vol. 4-5, pp. 25-33
Open Access | Times Cited: 50
The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs
Nico P.M. Smit, L. Renee Ruhaak, Fred P.H.T.M. Romijn, et al.
Journal of the American Society for Mass Spectrometry (2021) Vol. 32, Iss. 3, pp. 636-647
Open Access | Times Cited: 38
Automated proteomic sample preparation: The key component for high throughput and quantitative mass spectrometry analysis
Qin Fu, Christopher I. Murray, Oleg A. Karpov, et al.
Mass Spectrometry Reviews (2021) Vol. 42, Iss. 2, pp. 873-886
Open Access | Times Cited: 34
Update on the laboratory investigation of dyslipidemias
Indra Ramasamy
Clinica Chimica Acta (2018) Vol. 479, pp. 103-125
Closed Access | Times Cited: 45
Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humans
Geerte Hoeke, Kimberly J. Nahon, Leontine E. H. Bakker, et al.
Journal of clinical lipidology (2017) Vol. 11, Iss. 4, pp. 920-928.e2
Closed Access | Times Cited: 43
Page 1 - Next Page

Scroll to top